Yrd. Doç. Dr. Mustafa Kemal Gül

  • Uzmanlık Alanları: Kanser moleküler biyolojisi, Kanser genetiği
Eğitim ve Uzmanlık
Karadeniz Teknik Üniversitesi Tıp Fakültesi
Ondokuz Mayıs Üniversitesi Tıp Fakültesi İç Hastalıkları
Ege Üniversitesi Tıp Fakültesi Tıbbi Onkoloji
 
 
Targeting apoptosis in the hormone -and drug-resistant prostate canser cell line,DU-145, by gossypol/ zoledronic acid combination,
Overcoming drug resistance in hormone -and drug- refractory prostate canser cell line, PC-3 by docetaxel and gossypol combination,
Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-I and Ltbeta-R in hormone-and drug resistant prostate canser cell line, DU-145,
Docetaxel / zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate canser cells,
Profiling of angiogenic cytokines produced by hormone-and drug- refractory prostate canser cell Lines, PC-3 and DU-145 before and after treatment with gossypol
Renal Hücreli Karsinom, Troid ve Parotis Bezi Metastazı: Bir Olgu Sunumu ve Literatürün Gözden Geçirilmesi
Rektal Skuamöz Hücreli Karsinom: Bir Olgu Sunumu ve Literatürün Gözden Geçirilmesi
Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck canser